 Manufacturer: Baxter Corporation
Generic Name: Anti-Hemophilic Factor VIII (Recombinant)-rAHF
Indications: The use of Recombinate rAHF is indicated in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes. Recombinate rAHF is also indicated in the perioperative management of patients with hemophilia A (classical hemophilia).
Recombinate Product Insert
How Supplied: Factor products are supplied in vials sizes of varying International Units (iu). Vial sizes (iu sizes) may change with each new lot of product manufactured. Vial sizes may range from approximately 200 - 1500 iu per vial.
Available Sizes |
NDC Numbers |
Recombinate - Low Range |
00944-2938-01 |
Recombiante - Mid Range |
00944-2938-02 |
Recombinate - High Range |
00944-2938-03 |
http://www.baxter.com/ |
